These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4821440)

  • 21. Hydroxyproline excretion in the urine as a measure of anti-inflammatory effect in rheumatic patients using naproxen.
    Tiselius P
    Scand J Rheumatol Suppl; 1973; 2():109-12. PubMed ID: 4590033
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological properties of naproxen.
    Roszkowski AP; Rooks W; Tomolonis A; Miller L; Pelczarska AB
    Scand J Rheumatol Suppl; 1973; 2():12-9. PubMed ID: 4604902
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of acute gout with naproxen.
    Willkens RF; Case JB
    Scand J Rheumatol Suppl; 1973; 2():69-71. PubMed ID: 4590054
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biochemical studies on action mechnism of a new anti-inflammatory agent, naproxen (1). Effects of naproxen on changes in connective tissue components due to inflammation].
    Suzuki Y; Ito M; Hamaguchi Y; Yamagami I
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):465-77. PubMed ID: 4475011
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of acute attacks of gout with naproxen-C 1674].
    Cuq P
    Scand J Rheumatol Suppl; 1973; 2():64-8. PubMed ID: 4590053
    [No Abstract]   [Full Text] [Related]  

  • 26. [Naproxen in osteoarthritis].
    Poal J; de Anta J; Reyes J
    Scand J Rheumatol Suppl; 1973; 2():77-9. PubMed ID: 4590056
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetic and metabolic studies.
    Nash JF; Carmichael RH; Ridolfo AS; Spradlin CT
    J Rheumatol Suppl; 1980; 6():12-9. PubMed ID: 6930483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological studies on drug inteaction--drug interactions on the inhibitory effects of capillary permeability and the analgesic effects].
    Ozawa H; Ikeda M
    Yakugaku Zasshi; 1974 Dec; 94(12):1524-30. PubMed ID: 4477185
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical trial of naproxen in the treatment of degenerative arthropathy (osteoarthritis)].
    Fdez del Vallado P; Baños JG; Postigo Alvarez JL
    Scand J Rheumatol Suppl; 1973; 2():72-6. PubMed ID: 4590055
    [No Abstract]   [Full Text] [Related]  

  • 30. [A trial on the efficiency of naproxen in rheumatoid arthritis].
    Borrachero J; Alcalde A
    Scand J Rheumatol Suppl; 1973; 2():140-4. PubMed ID: 4590039
    [No Abstract]   [Full Text] [Related]  

  • 31. Analgesic activity of oral naproxen in patients with postoperative pain.
    Stetson JB; Robinson K; Wardell WM; Lasagna L
    Scand J Rheumatol Suppl; 1973; 2():50-5. PubMed ID: 4590050
    [No Abstract]   [Full Text] [Related]  

  • 32. Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration.
    Rubin A; Rodda BE; Warrick P; Ridolfo AS; Gruber CM
    J Pharm Sci; 1972 May; 61(5):739-45. PubMed ID: 5035782
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of an open therapeutic trial with naproxen in patients with degenerative joint diseases].
    Binzus G; Josenhans G
    Scand J Rheumatol Suppl; 1973; 2():80-8. PubMed ID: 4590057
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of oral aspirin and oxaprozin on the development of lupus-like disease in MRL/1 mice.
    Carlson RP; Gilman SC; Hodge TG; O'Neill-Davis L; Blazek EM; Lewis AJ
    J Immunopharmacol; 1984; 6(1-2):69-78. PubMed ID: 6432913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical effects of naproxen and indomethacin in the treatment of progressive chronic polyarthritis (an interim report)].
    Winer J; Wagenhäuser F; Nározná H
    Scand J Rheumatol Suppl; 1973; 2():155-8. PubMed ID: 4590042
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical evaluation of naproxen in the treatment of osteoarthritis--double-blind, cross-over trial.
    Kageyama T
    Scand J Rheumatol Suppl; 1973; 2():94-100. PubMed ID: 4590059
    [No Abstract]   [Full Text] [Related]  

  • 37. Long term study of naproxen challenged by a short-term double blind cross-over study with placebo in rheumatoid patients.
    Lussier A; Myhal D; Boost G; Varady J; Segre E; Strauss W
    Scand J Rheumatol Suppl; 1973; 2():113-20. PubMed ID: 4590034
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men].
    Populaire P; Terlain B; Pascal S; Decouvelaere B; Renard A; Thomas JP
    Ann Pharm Fr; 1973 Dec; 31(12):735-49. PubMed ID: 4804224
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results from an open trial with naproxen in chronic polyarthritis and other rheumatic diseases].
    Eberl R; Tausch G; Sochor H; Binzus G
    Scand J Rheumatol Suppl; 1973; 2():150-4. PubMed ID: 4590041
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of non-steroidal anti-inflammatory agents.
    Champion GD; Graham GG
    Aust N Z J Med; 1978; 8 Suppl 1():94-100. PubMed ID: 365162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.